Millipore Sigma Vibrant Logo

05-1319 Anti-EZH2 Antibody, clone BD43

View This Product on Sigma-Aldrich
05-1319
100 µg  
価格を検索中…
価格が見つかりません
Minimum Quantity needs to be mulitiple of
Maximum Quantity is
弊社照会 詳細を表示 
値引
()
 
弊社照会
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      Special Offers[海外情報]

       

      お問合せください

      概要

      Replacement Information

      Special Offers[海外情報]

      主要スペック表

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H, MWBMPurifiedMonoclonal Antibody
      Description
      Catalogue Number05-1319
      Replaces04-1047
      DescriptionAnti-EZH2 Antibody, clone BD43
      Alternate Names
      • Enhancer of zeste homolog 2
      • Lysine N-methyltransferase 6
      • enhancer of zeste 2
      • enhancer of zeste homolog 2
      • ENX-1
      Background InformationEZH2 (enhancer of zeste homologue 2), also known as Enx1, is a member of the polycomb group of proteins and is involved in cell cycle regulation. EZH2 represses transcription via trimethylation of histone H3 on Lys27 (H3K27) as indicated by the fact that RNAi-mediated knockdown of EZH2 resulted in a loss of H3K27 trimethylation. EZH2 is ubiquitously expressed during early embryo genesis, and becomes restricted to the central and peripheral nervous systems and sites of fetal hematopoiesis during later development. In the adult, EZH2 is restricted to the spleen, testis and placenta. EZH2 and BMI-1 genes are coexpressed in Reed-Sternberg cells of Hodgkin’s disease. Coexpression of BMI-1 and EZH2 is also associated with cycling cells and degree of malignancy in B-cell non-Hogkin’s lymphoma. EZH2 is involved in the progression of prostate cancer, and has been identified as a marker of aggressive breast cancer. Two transcript variants encoding distinct isoforms have been identified for this gene
      References
      Product Information
      FormatPurified
      Control
      • HeLa Nuclear Extracts
      PresentationPurified immunoglobulin in buffer containing 0.1 M Tris-Glycine (pH7.4) 150 mM NaCl with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationUse Anti-EZH2 Antibody, clone BD43 (Mouse Monoclonal Antibody) validated in WB to detect EZH2 also known as Lysine N-methyltransferase 6, enhancer of zeste homolog 2, ENX-1.
      Key Applications
      • Western Blotting
      Biological Information
      ImmunogenRecombinant fusion protein of amino acids 1-286 of human EZH2 tagged with MBP.
      CloneBD43
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostMouse
      SpecificityThis antibody recognizes human EZH2 (~98kDa).
      IsotypeIgG1κ
      Species Reactivity
      • Human
      • Mouse
      Species Reactivity NoteHuman, and mouse. Not tested in other species.
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Entrez Gene SummaryThis gene encodes a member of the Polycomb-group (PcG) family. PcG family members form multimeric protein complexes, which are involved in maintaining the transcriptional repressive state of genes over successive cell generations. This protein associates with the embryonic ectoderm development protein, the VAV1 oncoprotein, and the X-linked nuclear protein. This protein may play a role in the hematopoietic and central nervous systems. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq
      Gene Symbol
      • EZH2
      • KMT6
      Purification MethodProtein G Purified
      UniProt Number
      UniProt SummaryFunction: Polycomb group (PcG) protein. Catalytic subunit of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' and 'Lys-27' of histone H3, leading to transcriptional repression of the affected target gene. Able to mono-, di- and trimethylate 'Lys-27' of histone H3 to form H3K27me1, H3K27me2 and H3K27me3, respectively. Compared to EZH2-containing complexes, it is more abundant in embryonic stem cells and plays a major role in forming H3K27me3, which is required for embryonic stem cell identity and proper differentiation. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1 and CDKN2A.
      Catalytic activity: S-adenosyl-L-methionine + histone L-lysine = S-adenosyl-L-homocysteine + histone N(6)-methyl-L-lysine.
      Subunit structure: Binds ATRX via the SET domain Probable. Component of the PRC2/EED-EZH2 complex, which includes EED, EZH2, SUZ12, RBBP4 and RBBP7 and possibly AEBP2. The minimum components required for methyltransferase activity of the PRC2/EED-EZH2 complex are EED, EZH2 and SUZ12. The PRC2 complex may also interact with DNMT1, DNMT3A, DNMT3B and PHF1 via the EZH2 subunit and with SIRT1 via the SUZ12 subunit. Interacts with HDAC1 and HDAC2.
      Subcellular location: Nucleus.
      Tissue specificity: Expressed in many tissues. Overexpressed in numerous tumor types including carcinomas of the breast, colon, larynx, lymphoma and testis.
      Developmental stage: Expression decreases during senescence of embryonic fibroblasts (HEFs). Expression peaks at the G1/S phase boundary.
      Induction: Expression is induced by E2F1, E2F2 and E2F3. Expression is reduced in cells subject to numerous types of stress including UV-, IR- and bleomycin-induced DNA damage and by activation of TP53/p53.
      Post-translational modification: Phosphorylated by AKT1. Phosphorylation by AKT1 reduces methyltransferase activity.
      Sequence similarities Belongs to the histone-lysine methyltransferase family. EZ subfamily.
      Contains 1 SET domain.
      Caution: Two variants of the PRC2 complex have been described, termed PRC3 and PRC4. Each of the three complexes may include a different complement of EED isoforms, although the precise sequences of the isoforms in each complex have not been determined. The PRC2 and PRC4 complexes may also methylate 'Lys-26' of histone H1 in addition to 'Lys-27' of histone H3 (Ref.15 and Ref.19), although other studies have demonstrated no methylation of 'Lys-26' of histone H1 by PRC2.
      Molecular Weight~98 kDa
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceWestern Blot Analysis: 1:5,000 from a previous lot detected EZH2 of HeLa Nuclear extract.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      For maximum recovery of product, centrifuge the vial prior to removing the cap. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      05-1319 04053252476259

      Documentation

      Anti-EZH2 Antibody, clone BD43 (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      Anti-EZH2 Antibody, clone BD43 試験成績書(CoA)

      タイトルロット番号
      Anti-EZH2, clone BD43 3160180
      Anti-EZH2, clone BD43 - 2384003 2384003
      Anti-EZH2, clone BD43 - 1941605 1941605
      Anti-EZH2, clone BD43 - 2024190 2024190
      Anti-EZH2, clone BD43 - 3386426 3386426
      Anti-EZH2, clone BD43 - JBC1787309 JBC1787309
      Anti-EZH2, clone BD43 - NG1578248 NG1578248
      Anti-EZH2, clone BD43 - NG1651157 NG1651157
      Anti-EZH2, clone BD43 - NG1686566 NG1686566
      Anti-EZH2, clone BD43 - NG1720571 NG1720571

      参考資料

      参考資料の概要Pub Med ID
      The Scaffold attachment factor b1 (Safb1) regulates myogenic differentiation by facilitating the transition of myogenic gene chromatin from a repressed to an activated state.
      Hernández-Hernández, JM; Mallappa, C; Nasipak, BT; Oesterreich, S; Imbalzano, AN
      Nucleic acids research  41  5704-16  2013

      概要を表示する
      23609547 23609547
      Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and Polycomb-Repressive Complex 2.
      Pasini, Diego, et al.
      Genes Dev., 22: 1345-55 (2008)  2008

      概要を表示する
      18483221 18483221
      The polycomb group protein Suz12 is required for embryonic stem cell differentiation.
      Pasini, Diego, et al.
      Mol. Cell. Biol., 27: 3769-79 (2007)  2007

      概要を表示する
      17339329 17339329
      Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.
      Bracken, Adrian P, et al.
      Genes Dev., 20: 1123-36 (2006)  2006

      概要を表示する
      16618801 16618801